Representation in Clinical Trials

Research institutions have long struggled with accurate population representation in clinical trials. The growing proliferation of digital in healthcare ecosystems makes this more likely, but it is not perfect. UCLA Health’s Dr. Arash Naeim and Dr. Medell Briggs-Malonson share their efforts to progress the intersectionality of health technology and health audience in clinical trials and beyond. Verizon’s Robin Goldsmith and Ned Chini round out this conversation with the role devices and connectivity play in achieving representation.

Recent Episodes

Hospitals and surgery centers own millions of dollars in equipment — but owning assets and having actionable visibility into them are two different things. Most systems maintain inventories, yet many struggle with outdated records, fragmented tracking, and limited insight into useful life or service contracts. With nearly half of U.S. hospitals reporting negative operating…

Behind every city vote, hospital budget or zoning decision is a leader navigating tough, often conflicting priorities. Right now, public leaders are operating in an environment of rising healthcare costs, workforce shortages and heightened community expectations—especially within safety-net systems that collectively provide billions in uncompensated care each year. The stakes are real—they affect patients…

Artificial intelligence used to live in strategy decks and conference keynotes—but now it’s showing up in a very different place: right on the assembly tables where SPD technicians build trays for the next case. And it’s arriving at a time when the pressure on sterile processing has never been higher. As surgical volumes climb and…